collected tumor tissue from 74 primary testicular lymphoma patients, and examined macrophage markers, T-cell markers, B-cell marker, and checkpoint molecules, illustrating that PD-1- PD-L1 signaling have a promising role in clinical outcome (45). This evidence concerns the gene CD274 and neoplasm.